Investidor Profissional Gestao de Recursos Ltda. Boosts Stock Holdings in HCA Healthcare, Inc. $HCA

Investidor Profissional Gestao de Recursos Ltda. increased its position in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 52.2% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,867 shares of the company’s stock after purchasing an additional 2,354 shares during the period. HCA Healthcare makes up approximately 1.3% of Investidor Profissional Gestao de Recursos Ltda.’s portfolio, making the stock its 12th largest position. Investidor Profissional Gestao de Recursos Ltda.’s holdings in HCA Healthcare were worth $2,631,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Empowered Funds LLC raised its position in shares of HCA Healthcare by 10.0% during the 2nd quarter. Empowered Funds LLC now owns 31,401 shares of the company’s stock valued at $12,030,000 after acquiring an additional 2,846 shares in the last quarter. Pinnacle Wealth Planning Services Inc. increased its stake in shares of HCA Healthcare by 38.9% during the 2nd quarter. Pinnacle Wealth Planning Services Inc. now owns 979 shares of the company’s stock worth $375,000 after purchasing an additional 274 shares during the last quarter. Mount Lucas Management LP acquired a new position in HCA Healthcare during the second quarter worth $716,000. LSV Asset Management lifted its stake in shares of HCA Healthcare by 0.4% in the second quarter. LSV Asset Management now owns 868,849 shares of the company’s stock worth $332,856,000 after buying an additional 3,396 shares during the last quarter. Finally, Intrust Bank NA boosted its position in shares of HCA Healthcare by 22.2% during the 2nd quarter. Intrust Bank NA now owns 71,963 shares of the company’s stock valued at $27,569,000 after acquiring an additional 13,089 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the subject of several analyst reports. Raymond James Financial set a $525.00 target price on HCA Healthcare in a research report on Monday, October 27th. Wall Street Zen upgraded shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 25th. Truist Financial upped their target price on shares of HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. TD Cowen boosted their price target on shares of HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Finally, Royal Bank Of Canada upped their target price on HCA Healthcare from $449.00 to $482.00 and gave the stock an “outperform” rating in a report on Monday, October 27th. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $474.53.

View Our Latest Analysis on HCA Healthcare

HCA Healthcare Stock Performance

Shares of HCA opened at $478.64 on Wednesday. The firm has a market cap of $109.22 billion, a P/E ratio of 18.50, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. The business has a 50-day moving average of $436.04 and a 200 day moving average of $398.67. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $480.00.

HCA Healthcare (NYSE:HCAGet Free Report) last released its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same period in the previous year, the business earned $4.90 EPS. HCA Healthcare’s revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s dividend payout ratio is 11.13%.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael S. Cuffe sold 3,836 shares of the firm’s stock in a transaction that occurred on Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This trade represents a 10.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

See Also

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.